Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/48428
Title: Flavonoids from eupatorium illitum and their antiproliferative activities
Authors: Castillo, Quírico A.
Triana, Jorge
Eiroa, José L. 
Padrón, José M.
Plata, Gabriela B.
Abel-Santos, Ernesto V.
Báez, Luis A.
Rodríguez, Diana C.
Jiménez, Marco A.
Pérez-Pujols, María F.
UNESCO Clasification: 32 Ciencias médicas
3208 Farmacodinámica
Keywords: Eupatorium illitum
Ermanin
4-Hydroxybenzoic acid
Kumatakenin
7-Methoxy-aromadendrin, et al
Issue Date: 2015
Journal: Pharmacognosy Journal 
Abstract: To isolate the chemical constituents of the aerial parts from Eupatorium illitum, elucidate their structures and evaluate their antiproliferative activity on human cancer cell lines. Materials and Methods: The ethanolic extract of Eupatorium illitum afforded five compounds, which were characterized using spectroscopic techniques and by comparison with data from the literature. Antiproliferative activities of selected isolates were evaluated. Results: The flavonoids Kumatakenin (1), Ermanin (2), 7-methoxy-aromadendrin (3) and Naringenin (4), together with 4-hydroxybenzoic acid (5) were isolated. Compounds 1, 2, 4 and 5 were evaluated for their antiproliferative activity on the human cancer cell lines A549 (lung), HBL-100 (breast), HeLa (cervix), SW1573 (lung), and T-47D (breast) presenting a wide range of bioactivities. In general, best results were observed for 5. Conclusion: Compounds 1-5 are reported for first time from Eupatorium illitum. Isolated phytochemicals show moderate to low antiproliferative activities when evaluated on the aforementioned human cancer cell lines.
URI: http://hdl.handle.net/10553/48428
ISSN: 0975-3575
DOI: 10.5530/pj.2015.3.6
Source: Pharmacognosy Journal [0975-3575], v. 7 (3), p. 178-181
Appears in Collections:Artículos
Thumbnail
Adobe PDF (465,21 kB)
Show full item record

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.